Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Lothar Daum"'
Autor:
Lothar Daum, Mark A. Miller, Gregory Hicklin, John C. Marshall, Christopher J. Doig, Edward A. Panacek, Leah Teoh, William T. Barchuk, Lori Van Meter, Martin Kaul, Rodger D. MacArthur, Timothy E Albertson, David H. Johnson, Steven Fischkoff, Stanley Lemeshow, Steven B. Johnson
Publikováno v:
Critical Care Medicine. 32:2173-2182
Objective: To evaluate whether administration of afelimomab, an anti-tumor necrosis factor F(ab')2 monoclonal antibody fragment, would reduce 28-day all-cause mortality in patients with severe sepsis and elevated serum levels of IL-6. Design: Prospec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::31daac71acd7f0379cbd608cd3cac193
https://doi.org/10.1097/01.ccm.0000145229.59014.6c
https://doi.org/10.1097/01.ccm.0000145229.59014.6c
Autor:
David F. Treacher, Jurgen Eiselstein, Carola Wiegand-Lohnert, Sheila Willatts, Joachim Eckart, Friedrich Grimminger, Lothar Daum, Felix Stockenhuber, Stuart Withington, Joachim Kempeni, Martin Kaul, Dietmar Krausch, Carmen Bouza, Konrad Reinhart
Publikováno v:
Critical Care Medicine. 24:733-742
To investigate the safety, biological effects, and efficacy of the anti-tumor necrosis factor (TNF) antibody fragment, MAK 195F, in a phase II trial in patient with severe sepsis.Prospective, randomized, open label, placebo-controlled, dose-ranging,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fd65a442c88c9a023587f9bfca3092a8
https://doi.org/10.1097/00003246-199605000-00003
https://doi.org/10.1097/00003246-199605000-00003
Autor:
Edward A Panacek, John C Marshall, Timothy E Albertson, David H Johnson, Steven Johnson, Rodger D MacArthur, Mark Miller, William T Barchuk, Steven Fischkoff, Martin Kaul, Leah Teoh, Lori Van Meter, Lothar Daum, Stanley Lemeshow, Gregory Hicklin, Christopher Doig
Publikováno v:
Critical Care Medicine; Nov2004, Vol. 32 Issue 11, p2173-2182, 10p